330 related articles for article (PubMed ID: 25319650)
1. Modulating the tumor microenvironment with RNA interference as a cancer treatment strategy.
Zins K; Sioud M; Aharinejad S; Lucas T; Abraham D
Methods Mol Biol; 2015; 1218():143-61. PubMed ID: 25319650
[TBL] [Abstract][Full Text] [Related]
2. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.
Aharinejad S; Paulus P; Sioud M; Hofmann M; Zins K; Schäfer R; Stanley ER; Abraham D
Cancer Res; 2004 Aug; 64(15):5378-84. PubMed ID: 15289345
[TBL] [Abstract][Full Text] [Related]
3. Targeting stromal-cancer cell interactions with siRNAs.
Aharinejad S; Sioud M; Lucas T; Abraham D
Methods Mol Biol; 2009; 487():243-66. PubMed ID: 19301651
[TBL] [Abstract][Full Text] [Related]
4. Target validation using RNA interference in solid tumors.
Aharinejad S; Sioud M; Lucas T; Abraham D
Methods Mol Biol; 2007; 361():227-38. PubMed ID: 17172715
[TBL] [Abstract][Full Text] [Related]
5. Macrophages regulate the angiogenic switch in a mouse model of breast cancer.
Lin EY; Li JF; Gnatovskiy L; Deng Y; Zhu L; Grzesik DA; Qian H; Xue XN; Pollard JW
Cancer Res; 2006 Dec; 66(23):11238-46. PubMed ID: 17114237
[TBL] [Abstract][Full Text] [Related]
6. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
Zins K; Abraham D; Sioud M; Aharinejad S
Cancer Res; 2007 Feb; 67(3):1038-45. PubMed ID: 17283136
[TBL] [Abstract][Full Text] [Related]
7. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
[TBL] [Abstract][Full Text] [Related]
8. Biomechanical forces shape the tumor microenvironment.
Shieh AC
Ann Biomed Eng; 2011 May; 39(5):1379-89. PubMed ID: 21253819
[TBL] [Abstract][Full Text] [Related]
9. Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment.
Zhang M; Yan L; Kim JA
Cancer Gene Ther; 2015 Oct; 22(10):463-74. PubMed ID: 26403072
[TBL] [Abstract][Full Text] [Related]
10. Tumor-stromal cell interactions and opportunities for therapeutic intervention.
Udagawa T; Wood M
Curr Opin Pharmacol; 2010 Aug; 10(4):369-74. PubMed ID: 20638903
[TBL] [Abstract][Full Text] [Related]
11. Delivery of small interfering RNA against Nogo-B receptor via tumor-acidity responsive nanoparticles for tumor vessel normalization and metastasis suppression.
Wang B; Ding Y; Zhao X; Han X; Yang N; Zhang Y; Zhao Y; Zhao X; Taleb M; Miao QR; Nie G
Biomaterials; 2018 Aug; 175():110-122. PubMed ID: 29803999
[TBL] [Abstract][Full Text] [Related]
12. CoREST1 promotes tumor formation and tumor stroma interactions in a mouse model of breast cancer.
Mazumdar S; Arendt LM; Phillips S; Sedic M; Kuperwasser C; Gill G
PLoS One; 2015; 10(3):e0121281. PubMed ID: 25793264
[TBL] [Abstract][Full Text] [Related]
13. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells.
Mueller MM; Fusenig NE
Differentiation; 2002 Dec; 70(9-10):486-97. PubMed ID: 12492491
[TBL] [Abstract][Full Text] [Related]
14. The possible mechanisms of tumor progression via CSF-1/CSF-1R pathway activation.
Huang L; Xu X; Hao Y
Rom J Morphol Embryol; 2014; 55(2 Suppl):501-6. PubMed ID: 25178319
[TBL] [Abstract][Full Text] [Related]
15. Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts.
Paulus P; Stanley ER; Schäfer R; Abraham D; Aharinejad S
Cancer Res; 2006 Apr; 66(8):4349-56. PubMed ID: 16618760
[TBL] [Abstract][Full Text] [Related]
16. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
17. Metabolic reprogramming of the tumour microenvironment.
Xing Y; Zhao S; Zhou BP; Mi J
FEBS J; 2015 Oct; 282(20):3892-8. PubMed ID: 26255648
[TBL] [Abstract][Full Text] [Related]
18. Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice.
Aharinejad S; Abraham D; Paulus P; Abri H; Hofmann M; Grossschmidt K; Schäfer R; Stanley ER; Hofbauer R
Cancer Res; 2002 Sep; 62(18):5317-24. PubMed ID: 12235002
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
20. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
